フローチャートでわかる　小児てんかん診療ガイド　改訂第2版

出版社： 診断と治療社
著者：
発行日： 2022-06-17
分野： 臨床医学：内科  >  小児科学一般
ISBN： 9784787825216
電子書籍版： 2022-06-17 （電子版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

7,920 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

7,920 円(税込)

購入する

商品紹介

2011年刊行の初版から，新規項目と最新情報を加えてアップデート！　発症年齢，発作の誘因など発作のおこりかたや様相から発作型を診断し，そこから最終的に診断に至るプロセスを，フローチャートと表を用いて解説．さらに，代表的な症例を呈示して，病歴，脳波，画像検査なども多数掲載した．どのように発作型をイメージして鑑別ポイントとなる情報を問診すべきかがわかる，小児のてんかん診療に必携の1冊．

目次

  • 第1章　総　論
    　1　てんかんの定義と分類
    　2　小児てんかんの特徴
    　3　小児てんかんの診断
    　4　てんかんおよびけいれん性疾患の脳波
    　5　併存症：神経発達症
    　6　併存症：重症心身障害児
    　7　小児てんかんの薬物治療
    　8　外科治療
    　9　食事療法（ケトン食）
    　10　小児てんかんと学校生活
    　11　てんかんの移行期医療
    　12　小児てんかんに関係する公的補助

    第2章　新生児〜乳児期早期の発作（新生児期～生後2か月）
    　1　けいれんや微細な症状の発作
    　2　筋攣縮や短い強直を示す発作

    第3章　乳児期の発作（生後3〜12か月）
    　1　けいれんあるいは類縁の運動症状を示す発作
    　2　筋攣縮や短い強直を示す発作
    　3　動作停止，意識障害や異常行動を示す発作

    第4章　幼児期前半の発作（1〜4歳）
    　1　けいれんあるいは類縁の運動症状を示す発作
    　2　筋攣縮や短い強直を示す発作
    　3　脱力や失立・転倒を示す発作
    　4　動作停止，意識障害や異常行動を示す発作

    第5章　幼児期後半〜学童期中期の発作（5〜9歳）
    　1　けいれんあるいは類縁の運動症状を示す発作
    　2　筋攣縮や短い強直を示す発作
    　3　脱力や失立・転倒を示す発作
    　4　動作停止，意識障害や異常行動を示す発作

    第6章　学童期後期〜思春期以降の発作（10歳以降）
    　1　けいれんあるいは類縁の運動症状を示す発作
    　2　筋攣縮や短い強直を示す発作
    　3　脱力や失立・転倒を示す発作
    　4　動作停止，意識障害や異常行動を示す発作

    第7章　特殊な発作およびてんかん
    　1　てんかん重積状態
    　2　感覚発作・情動発作
    　3　反射てんかん・発作
    　4　特殊な症状の発作
    　5　自己免疫性脳炎および類縁病態とてんかん
    　6　突然死

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 総論

P.8 掲載の参考文献
1) Fisher RS, et al.:Epileptic seizures and epilepsy:definitions proposed by the International League Against Epilepsy(ILAE)and the International Bureau for Epilepsy(IBE). Epilepsia 46:470-472, 2005
PubMed
2) Hauser WA, et al.:Prevalence of epilepsy in Rochester, Minnesota:1940-1980. Epilepsia 32:429-445, 1991
PubMed
3) Fisher RS, et al.:ILAE official report:a practical clinical definition of epilepsy. Epilepsia 55:475-482, 2014
PubMed
4) 日本てんかん学会ガイドライン作成委員会(訳):てんかんの実用的臨床定義. てんかん研究32:579-588, 2015
 
5) Berg AT, et al.:The risk of seizure recurrence following a first unprovoked seizure:a quantitative review. Neurology 41:965-972, 1991
PubMed
6) Kim LG, et al.:Prediction of risk of seizure recurrence after a single seizure and early epilepsy:further results from the MESS trial. Lancet Neurol 5:317-322, 2006
PubMed
7) Hauser WA, et al.:Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 338:429-434, 1998
PubMed
8) Commission on Classification and Terminology of the International League Against Epilepsy:Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489-501, 1981
PubMed
9) Commission on Classification and Terminology of the International League Against Epilepsy:Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399, 1989
PubMed
10) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
11) Berg AT, et al.:Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51:676-685, 2010
PubMed
12) 日本てんかん学会分類用語委員会(訳):てんかん発作およびてんかんを体系化するための用語と概念の改訂:ILAE分類・用語委員会報告(2005～2009年). てんかん研究28:515-525, 2011
 
13) Fisher RS, et al.:2017 International League Against Epilepsy classifications of seizures and epilepsy are steps in the right direction. Epilepsia 60:1040-1044, 2019
PubMed
14) Scheffer IE, et al.:ILAE classification of the epilepsies:Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:512-521, 2017
PubMed
15) Luders H, et al.:Critique of the 2017 epileptic seizure and epilepsy classifications. Epilepsia 60:1032-1039, 2019
PubMed
P.15 掲載の参考文献
1) Moshe SL:Concluding remarks and future plans. In:Nehlig A, et al.(eds), Childhood Epilepsies and Brain Development. John Libbey, London, 307-310, 1999
 
2) 大田原俊輔:年齢依存性てんかん性脳症に関する研究とそのてんかん学への寄与. てんかん治療研究振興財団研究年報12:1-14, 2000
 
3) 大塚頌子, 他:正常脳波の年齢的変化(1):小児(新生児を含む). 日本臨床神経生理学会(編), モノグラフ 臨床脳波を基礎から学ぶ人のために. 第2版, 診断と治療社, 74-83, 2019
 
4) 石田純郎:岡山県における小児てんかんの神経疫学的研究. てんかん研究2:1-12, 1984
 
5) 大田原俊輔:年齢依存性てんかん性脳症に関する研究. 脳と発達9:2-21, 1977
 
6) Ohtahara S, et al.:Epileptic encephalopathies in early infancy with suppression-burst. J Clin Neurophysiol 20:398-407, 2003
 
7) Berg AT, et al.:Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51:676-685, 2010
PubMed
8) 日本てんかん学会分類用語委員会(訳):てんかん発作およびてんかんを体系化するための用語と概念の改訂:ILAE分類・用語委員会報告(2005～2009年). てんかん研究28:515-525, 2011
 
9) Watanabe K, et al.:Benign partial epilepsies in infancy. Brain Dev 22:296-300, 2000
PubMed
10) Okumura A, et al.:Long-term follow-up of patients with benign partial epilepsy in infancy. Epilepsia 47:181-185, 2006
PubMed
11) Ferrie C, et al.:Panayiotopoulos syndrome:a consensus view. Dev Med Child Neurol 48:236-240, 2006
PubMed
12) Niedermeyer E:Epileptic seizure disorders. In:Niedermeyer E, et al.(eds), Electroencephalography:Basic Principles, Clinical Applications, and Related Fields. 5th ed, Lippincott Williams & Wilkins, Philadelphia, 570-619, 2005
 
P.25 掲載の参考文献
1) 石切山 敏:家系図・核型の基礎. 小児科診療72:17-24, 2009
 
2) Leen WG, et al.:Glucose transporter-1 deficiency syndrome:the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655-670, 2010
PubMed
3) Matsuoka H, et al.:Neuropsychological EEG activation in patients with epilepsy. Brain 123:318-330, 2000
PubMed
4) Kahane P, et al.:From hypothalamic hamartoma to cortex:what can be learnt from depth recordings and stimulation? Epileptic Disord 5:205-217, 2003
PubMed
5) 犬塚幹, 他:恐怖発作を示した幼児例. 脳と発達35:336-341, 2003
 
6) Okumura A, et al.:Periventricular leukomalacia and West syndrome. Dev Med Child Neurol 38:13-18, 1996
PubMed
7) Endoh F, et al.:Electroencephalographic changes before the onset of symptomatic West syndrome. Brain Dev 29:630-638, 2007
PubMed
8) Yoshinaga H, et al.:Incidence of epileptic discharge in various epileptic syndromes. Pediatr Neurol 25:38-42, 2001
PubMed
9) Panayiotopoulos CP:Epilogue and conclusions. In:Panayiotopoulos CP, Benign Childhood Partial Seizures and Related Epileptic Syndromes. John Libbey, London, 361-363, 1999
 
10) Scheffer IE, et al.:ILAE classification of the epilepsies:Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:512-521, 2017
PubMed
11) 日本小児神経学会(監), 小児急性脳症診療ガイドライン策定委員会(編):小児急性脳症診療ガイドライン2016. 診断と治療社, 2016
 
12) Stefan H, et al.:Ictal and interictal activity in partial epilepsy recorded with multichannel magnetoelectroencephalography:correlation of electroencephalography/electrocorticography, magnetic resonance imaging, single photon emission computed tomography, and positron emission tomography findings. Epilepsia 33:874-887, 1992
PubMed
13) Dunn P, et al.:Next generation sequencing methods for diagnosis of epilepsy syndromes. Front Genet 9:20, 2018
PubMed
14) Hattori J, et al.:A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 49:626-633, 2008
PubMed
P.43 掲載の参考文献
1) 大塚頌子(監), 小林勝弘:小児脳波-判読のためのアプローチ. 診断と治療社, 2008
 
2) Reilly EL:Nasopharyngeal, sphenoidal, and other electrodes. In:Niedermeyer E, et al.(eds), Electroencephalography:Basic Principles, Clinical Applications, and Related Field. 5th ed, Lippincott Williams & Wilkins, Philadelphia, 725-732, 2005
 
3) 日本臨床神経生理学会臨床脳波検査基準改訂委員会:改訂臨床脳波検査基準2002. 臨床神経生理学31:221-242, 2003
 
4) 大塚頌子, 他:正常脳波の年齢的変化(1):小児(新生児を含む). 日本臨床神経生理学会(編), モノグラフ 臨床脳波を基礎から学ぶ人のために. 第2版, 診断と治療社, 74-83, 2019
 
5) 大田原俊輔:小児脳波の記録法. 臨床脳波9:72-80, 1967
 
6) 脳波等神経生理検査時の鎮静における医療安全に関する提言・指針作成ワーキンググループ:脳波等神経生理検査時の鎮静における医療安全に関する提言・指針. 脳と発達51:409-410, 2019
 
7) 本間三郎:脳内電位発生源の特定 脳波双極子追跡. 日本評論社, 1997
 
8) Takahashi T:Activation methods. In:Niedermeyer E, et al.(eds), Electroencephalography:Basic Principles, Clinical Applications, and Related Fields. 5th ed, Lippincott Williams & Wilkins, Philadelphia, 281-303, 2005
 
9) 米国睡眠医学会(原著), 日本睡眠学会(訳):AASM による睡眠および随伴イベントの判定マニュアル. Ver. 2.5, ライフサイエンス, 90, 2018
 
10) Flink R, et al.:Guidelines for the use of EEG methodology in the diagnosis of epilepsy. International League Against Epilepsy:commission report. Commission on European Affairs:Subcommission on European Guidelines. Acta Neurol Scand 106:1-7, 2002
PubMed
11) Hughes JR:Two forms of the 6/sec spike and wave complex. Electroencephalogr Clin Neurophysiol 48:535-550, 1980
PubMed
12) Eeg-Olofsson O:The development of the electroencephalogram in normal children from the age of 1 through 15 years. 14 and 6 Hz positive spike phenomenon. Neuropadiatrie 2:405-426, 1971
PubMed
13) Niedermeyer E:Abnormal EEG patterns:epileptic and paroxysmal. In:Niedermeyer E, et al.(eds), Electroencephalography:Basic Principles, Clinical Applications, and Related Fields. 5th ed, Lippincott Williams & Wilkins, Philadelphia, 255-280, 2005
 
14) Gibbs FA, et al.:Atlas of Electroencephalography:Neurological and Psychiatric Disorders. vol. 3, Addison-Wesley, Reading, 1964
 
15) Alvarez N, et al.:Paroxysmal spike and wave activity in drowsiness in young children:its relationship to febrile convulsions. Electroencephalogr Clin Neurophysiol 56:406-413, 1983
PubMed
16) Reilly EL:EEG recording and operation of the apparatus. In:Niedermeyer E, et al.(eds), Electroencephalography:Basic Principles, Clinical Applications, and Related Fields. 5th ed, Lippincott Williams & Wilkins, Philadelphia, 139-159, 2005
 
17) 日本臨床神経生理学会(旧日本脳波・筋電図学会)ペーパレス脳波計検討委員会:ペーパレス脳波計の性能と使用基準2000. 臨床神経生理学28:270-276, 2000
 
18) Kobayashi K, et al.:A storm of fast(40-150 Hz)oscillations during hypsarrhythmia in West syndrome. Ann Neurol 77:58-67, 2015
 
19) Frauscher B, et al.:High-frequency oscillations:The state of clinical research. Epilepsia 58:1316-1329, 2017
PubMed
P.46 掲載の参考文献
1) 日本てんかん学会(編):てんかんでみられる精神症状と心理学的課題. てんかん専門医ガイドブック てんかんにかかわる医師のための基本知識. 第2版, 診断と治療社, 342-348, 2020
 
2) 中川栄二:小児てんかんの治療up to date. 東京小児科医会報37:8-14, 2018
 
3) 高山留美子:てんかんと発達障害/知的障害との関係. 小出泰道(編著), はじめてのてんかん・けいれん診療. 日本医事新報社, 53-55, 2017
 
American Psychiatric Association(原著), 日本精神神経学会(監訳):DSM-5 精神疾患の分類と診断の手引. 医学書院, 2014
 
P.49 掲載の参考文献
1) Hadjipanayis A, et al.:Epilepsy in patients with cerebral palsy. Dev Med Child Neurol 39:659-663, 1997
PubMed
2) Zafeiriou DI, et al.:Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol 14:289-294, 1999
PubMed
3) 吉永治美:重症心身障害児のてんかん診療. 難病と在宅ケア26:45-48, 2020
 
4) Yoshinaga H, et al.:Utility of the scalp-recorded ictal EEG in childhood epilepsy. Epilepsia 42:772-777, 2001
PubMed
5) Shinnar S, et al.:Discontinuing antiepileptic drugs in children with epilepsy:A prospective study. Ann Neurol 35:534-545, 1994
PubMed
6) Tawfik R, et al.:Caregivers' perceptions following gastrostomy in severely disabled children with feeding problems. Dev Med Child Neurol 39:746-751, 1997
PubMed
7) Newman CJ, et al.:Sleep disorders in children with cerebral palsy. Dev Med Child Neurol 48:564-568, 2006
PubMed
8) Toledo M, et al.:Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures. Epilepsy Behav 63:57-62, 2016
PubMed
9) Proesmans M, et al.:Respiratory morbidity in children with profound intellectual and multiple disability. Pediatr Pulmonol 50:1033-1038, 2015
PubMed
10) Ishikawa N, et al.:High incidence of renal stones in severely disabled children with epilepsy treated with topiramate. Neuropediatrics 50:160-163, 2019
PubMed
11) Knorr M, et al.:Fanconi syndrome caused by antiepileptic therapy with valproic acid. Epilepsia 45:868-871, 2004
PubMed
12) Brodie MJ, et al.:Enzyme induction with antiepileptic drugs:cause for concern? Epilepsia 54:11-27, 2013
PubMed
13) Verrotti A, et al.:Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 52:199-211, 2011
PubMed
14) Kimura M, et al.:Seizure recurrence after reduction of an antiepileptic drug in patients with unprovoked seizures and severe neurological abnormalities. Psychiatry Clin Neurosci 54:41-44, 2000
PubMed
15) Karalok ZS, et al.:Risk factors for recurrence after drug withdrawal in childhood epilepsy. Brain Dev 42:35-40, 2020
PubMed
16) Scheffer IE, et al.:ILAE classification of the epilepsies:Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:512-521, 2017
PubMed
17) 松本昭子:重症心身障害児に伴うてんかん. 脳と発達22:149-153, 1990
 
P.69 掲載の参考文献
1) 日本てんかん学会ガイドライン作成委員会:小児てんかんの包括的治療ガイドライン. てんかん研究23:244-248, 2005
 
2) Hauser WA, et al.:Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 338:429-434, 1998
PubMed
3) Fisher RS, et al.:Epileptic seizures and epilepsy:definitions proposed by the International League Against Epilepsy(ILAE)and the International Bureau for Epilepsy(IBE). Epilepsia 46:470-472, 2005
PubMed
4) Fisher RS, et al.:ILAE official report:a practical clinical definition of epilepsy. Epilepsia 55:475-482, 2014
PubMed
5) Shinnar S, et al.:Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 48:140-147, 2000
 
6) Lerman P:Seizures induced or aggravated by anticonvulsants. Epilepsia 27:706-710, 1986
 
7) Ferrie C, et al.:Panayiotopoulos syndrome:a consensus view. Dev Med Child Neurol 48:236-240, 2006
PubMed
8) Kikumoto K, et al.:EEG and seizure exacerbation induced by carbamazepine in Panayiotoloulos syndrome. Epileptic Disord 8:53-56, 2006
PubMed
9) Camfield C, et al.:Management guidelines for children with idiopathic generalized epilepsy. Epilepsia 46(Suppl. 9):112-116, 2005
 
10) Inutsuka M, et al.:Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev 28:281-286, 2006
PubMed
11) Foldvary-Schaefer N, et al.:Catamenial epilepsy:pathophysiology, diagnosis and management. Neurology 61(Suppl. 2):S2-S15, 2003
 
12) Schmidt D, et al.:Drug resistance in epilepsy:putative neurobiologic and clinical mechanisms. Epilepsia 46:858-877, 2005
PubMed
13) 粟屋豊, 他:てんかん患者のquality of life(QOL)に関する大規模調査-患者と主治医の認識の差異-. てんかん研究25:414-424, 2008
 
14) 大塚頌子:てんかんと外来薬物療法. 小児神経学の進歩33:25-36, 2004
 
15) Levy RH, et al.:Drug absorption, distribution, and elimination. In:Levy RH, et al.(eds), Antiepileptic Drugs. 4th ed, Raven Press, New York, 13-30, 1995
 
16) Ozawa H, et al.:Oral high-dose phenobarbital therapy for early infantile epileptic encephalopathy. Pediatr Neurol 26:222-224, 2002
PubMed
17) Chung WH, et al.:Medical genetics:a marker for Stevens-Johnson syndrome. Nature 428:486, 2004
PubMed
18) Mushiroda T, et al.:Association of HLA-A*31:01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population. JAMA Neurol 75:842-849, 2018
 
19) 兼子直, 他:てんかんを持つ妊娠可能年齢の女性に対する治療ガイドライン. てんかん研究25:27-31, 2007
 
20) Kobayashi K, et al.:Action of antiepileptic drugs on neurons. Brain Dev 42:2-5, 2020
PubMed
21) Ohtsuka Y, et al.:Treatment of intractable childhood epilepsy with high-dose valproate. Epilepsia 33:158-164, 1992
PubMed
22) Dreifuss FE, et al.:Valproic acid hepatic fatalities:a retrospective review. Neurology 37:379-385, 1987
PubMed
23) 日本神経学会(監), 「てんかん診療ガイドライン」作成委員会(編):てんかん診療ガイドライン2018. 医学書院, 2018
 
24) Harden CL, et al.:Management issues for women with epilepsy-Focus on pregnancy(an evidence-based review):II. Teratogenesis and perinatal outcomes:Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1237-1246, 2009
 
25) Harden CL, et al.:Management issues for women with epilepsy-Focus on pregnancy(an evidence-based review):III. Vitamin K, folic acid, blood levels, and breast-feeding:Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1247-1255, 2009
 
26) Guberman AH, et al.:Lamotrigine-associated rash:risk/benefit considerations in adults and children. Epilepsia 40:985-991, 1999
PubMed
27) Tomson T, et al.:Comparative risk of major congenital malformations with eight different antiepileptic drugs:a prospective cohort study of the EURAP registry. Lancet Neurol 17:530-538, 2018
PubMed
28) Kroll-Seger J, et al.:Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics 37:325-329, 2006
PubMed
29) Scheuerle AE, et al.:Levetiracetam Pregnancy Registry:Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations. Birth Defects Res 111:872-887, 2019
 
30) Oguni H, et al.:Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 35:1140-1145, 1994
PubMed
31) 今井由生, 他:結節性臭素疹を生じた乳児例. 脳と発達41:462-464, 2009
 
32) Yoshinaga H, et al.:EEG in childhood absence epilepsy. Seizure 13:296-302, 2004
PubMed
33) Wyllie E, et al.(eds):Wyllie's Treatment of Epilepsy:Principles and Practice. 7th ed, Wolters Kluwer, Philadelphia, 2021
 
34) 日本TDM学会(編):抗てんかん薬TDM標準化ガイドライン2018. 金原出版, 2018
 
35) Patsalos PN, et al.:Clinically important drug interactions in epilepsy:general features and interactions between antiepileptic drugs. Lancet Neurol 2:347-356, 2003
PubMed
36) Wilkinson GR:Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211-2221, 2005
PubMed
37) Takano T, et al.:Seizure susceptibility due to antihistamines in febrile seizures. Pediatr Neurol 42:277-279, 2010
PubMed
38) 大塚頌子, 他:日本人の点頭てんかん患者に対するビガバトリン長期継続療法の安全性と有効性-多施設共同非盲検試験-. てんかん研究36:17-31, 2018
 
39) Zaccara G, et al.:Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 48:1223-1244, 2007
PubMed
40) Arif H, et al.:Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 68:1701-1709, 2007
PubMed
41) Hirsch LJ, et al.:Cross-sensitivity of skin rashes with antepileptic drug use. Neurology 71:1527-1534, 2008
 
43) 服部旬里:中心・側頭部に棘波をもつ良性小児てんかんと非定型良性部分てんかんにおける高次脳機能障害の検討. 脳と発達 34:484-490, 2002
Medical*Online
44) Mula M, et al.:Are psychiatric adverse events of antiepileitc drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia 48:2322-2326, 2007
 
45) Sazgar M, et al.:Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 33:227-234, 2005
PubMed
46) Gayatri NA, et al.:Aggravation of epilepsy by anti-epileptic drugs. Dev Med Child Neurol 48:394-398, 2006
PubMed
47) 大塚頌子:抗てんかん薬による発作の増悪. Epilepsy 3:117-122, 2009
Medical*Online
48) Ohtsuka Y, et al.:Nonconvulsive status epilepticus in childhood localization-related epilepsy. Epilepsia 40:1003-1010, 1999
PubMed
49) 大田原俊輔, 他:Induced Microseizures に関する臨床的脳波学的研究. てんかん研究1:51-60, 1983
 
50) Thomas P, et al.:Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 129:1281-1292, 2006
PubMed
51) 大塚頌子:小児てんかんにおける断薬過程に関する研究. てんかん研究2:122-133, 1984
 
52) Ohta H, et al.:Prognosis after withdrawal of antiepileptic drugs in childhood-onset cryptogenic localization-related epilepsies. Brain Dev26:19-25, 2004
 
53) 日本てんかん学会ガイドライン作成委員会:小児てんかんの薬物治療終結のガイドライン. てんかん研究28:40-47, 2010
 
54) Yamatogi Y, et al.:Prognosis of childhood epilepsy observed from long-term follow-ups for more than ten years. In:Sato T, et al.(eds), Antiepileptic Drugs and Pregnancy. Excerpta Medica, Amsterdam, 247-254, 1984
 
55) 大塚頌子, 他:てんかん診療におけるキャリーオーバー患者の問題. 日本臨牀68:77-81, 2010
 
56) Ohtsuka Y, et al.:Management of childhood-onset epilepsy evaluated with a long-term follow-up study. Epilepsy & Seizure 1:21-29, 2008
 
57) Josephson CB, et al.:Precision medicine:academic dreaming or clinical reality? Epilepsia 62(Suppl. 2):S78-S89, 2021
PubMed
58) Dunn P, et al.:Next generation sequencing methods for diagnosis of epilepsy syndromes. Front Genet 9:20, 2018
PubMed
59) 石井敦士:電位依存性ナトリウムイオンチャネルとてんかん. 脳と発達53:5-9, 2021
 
60) Wolff M, et al.:Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond. Epilepsia 60(Suppl. 3):S59-S67, 2019
 
61) Meisler MH, et al.:SCN8A encephalopathy:Research progress and prospects. Epilepsia 57:1027-1035, 2016
PubMed
62) van der Weide J, et al.:The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement. Pharmacogenetics 11:287-291, 2001
PubMed
63) Seo T, et al.:Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy. Pharmacogenomics 9:527-537, 2008
PubMed
64) Kuhara T, et al.:Identification of new biomarkers of pyridoxine-dependent epilepsy by GC/MS-based urine metabolomics. Anal Biochem 604:113739, 2020
PubMed
P.73 掲載の参考文献
1) Wiebe S, et al.:A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345:311-318, 2001
 
2) Kwan P, et al.:Definition of drug resistant epilepsy:consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069-1077, 2010
 
3) Berg AT, et al.:Remission of epilepsy after two drug failures in children:a prospective study. Ann Neurol 65:510-519, 2009
PubMed
4) 秋山倫之:高周波振動(HFO)の実際の記録・解析. 臨床神経生理学43:499-503, 2015
 
5) 池田昭夫:てんかん性DC電位(緩電位):総論. 臨床神経生理学43:483-488, 2015
 
6) Baba H, et al.:Surgical and developmental outcomes of corpus callosotomy for West syndrome in patients without MRI lesions. Epilepsia 59:2231-2239, 2018
PubMed
7) Elliott RE, et al.:Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy:Long-term outcomes and predictors of response. Epilepsy Behav 20:57-63, 2011
PubMed
8) Hampel KG, et al.:Cardiac-based vagus nerve stimulation reduced seizure duration in a patient with refractory epilepsy. Seizure 26:81-85, 2015
 
P.76 掲載の参考文献
1) Neal EG, et al.:The ketogenic diet for the treatment of childhood epilepsy:a randomised controlled trial. Lancet Neurol 7:500-506, 2008
PubMed
2) Nabbout R, et al.:Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children(FIRES). Epilepsia 51:2033-2037, 2010
PubMed
3) Cervenka MC, et al.:Establishing an Adult Epilepsy Diet Center:Experience, efficacy and challenges. Epilepsy Behav 58:61-68, 2016
PubMed
4) Gilbert DL, et al.:The ketogenic diet:seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 15:787-790, 2000
PubMed
5) Sondhi V, et al.:Efficacy of ketogenic diet, modified Atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy:A randomized clinical trial. JAMA Pediatr 174:944-951, 2020
PubMed
6) 藤井達哉(編):ケトン食の基礎から実践まで～ケトン食に関わるすべての方へ～. 第2版, 診断と治療社, 2018
 
7) 大阪府立病院機構大阪母子医療センター(監), 位田忍, 他(編):簡単・おいしい・アレンジしやすい治療のための継続できるケトン食レシピ. 診断と治療社, 2019
 
P.79 掲載の参考文献
1) 木村かほり, 他:てんかん患者の日常生活指導. 小児内科47:1525-1530, 2015
 
2) 最上友紀子:運動指導. 小出泰道(編著), はじめてのてんかん・けいれん診療. 日本医事新報社, 121-122, 2017
 
3) 徳村光昭:慢性疾患と学校生活管理指導表. チャイルドヘルス20:42-46, 2017
 
4) 関亨, 他:てんかん患児(者)の学校生活上のガイドライン-家族へのアンケート調査から-. 平成3年度厚生省心身障害者研究「小児慢性疾患のトータルケアーに関する研究」. 344-348, 1991
 
5) 長尾秀夫:てんかん児の生活支援と看護. 小児看護30:178-185, 2007
 
P.83 掲載の参考文献
1) Camfield P, et al.:The transition from pediatric to adult care for youth with epilepsy:Basic biological, sociological, and psychological issues. Epilepsy Behav 69:170-176, 2017
PubMed
2) Nabbout R, et al.:Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav 69:153-160, 2017
PubMed
3) Nabbout R, et al.:Outcome of childhood-onset epilepsy from adolescence to adulthood:Transition issues. Epilepsy Behav 69:161-169, 2017
PubMed
4) 大塚頌子, 他:日本におけるてんかんの実態 キャリーオーバー患者の問題. てんかん研究27:402-407, 2010
 
5) 渡辺雅子, 他:てんかんの, 小児から成人へのよりよいトランシションをめざして:報告と提言. てんかん研究31:30-39, 2013
 
6) 遠藤文香:てんかん患者の思春期, 成人期への移行問題. 小児内科47:1536-1539, 2015
 
7) American Epilepsy Society:Transitions from pediatric epilepsy to adult epilepsy care. 2013[www.aesnet.org]
 
8) Andrade DM, et al.:Epilepsy:Transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force. Epilepsia 58:1502-1517, 2017
PubMed
9) May TW, et al.:The efficacy of an educational treatment program for patients with epilepsy(MOSES):result of a controlled, randomized study. Epilepsia 43:539-549, 2002
PubMed
10) Sawicki GS, et al.:Measuring the transition readiness of youth with special healthcare needs:validation of the TRAQ-Transition Readiness Assessment Questionnaire. J Pediatr Psychol 36:160-171, 2011
PubMed
11) Borlot F, et al.:Epilepsy transition:Challenges of caring for adults with childhood-onset seizures. Epilepsia 55:1659-1666, 2014
PubMed
12) Yoshinaga H, et al.:Difficulty of transition to adult care in a patient with tuberous sclerosis:a case report. Epilepsy & Seizure 13:36-44, 2021
 
13) Thiele EA, et al.:Transition into adulthood:Tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis. Epilepsia 55(Suppl. 3):29-33, 2014
 
14) 吉永治美:重症心身障害児のてんかん診療. 難病と在宅ケア26:45-48, 2020
 
15) Vorderwulbecke BJ, et al.:Long-term outcome in adolescent-onset generalized genetic epilepsies. Epilepsia 58:1244-1250, 2017
PubMed
16) Tomson T, et al.:Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 56:1006-1019, 2015
PubMed
17) Yacubian EM:Juvenile myoclonic epilepsy:challenges on its 60th anniversary. Seizure 44:48-52, 2017
PubMed
18) Beghi E, et al.:Epidemiologic aspects:Lost in transition. Epilepsia 55(Suppl. 3):3-7, 2014
 

第2章 新生児～乳児期早期の発作 ( 新生児期～生後 2 か月 )

P.97 掲載の参考文献
1) Hill A, et al.:Neurologic disorders. In:Avery GB, et al.(eds), Neonatology:Pathophysiology and Management of the Newborn. 4th ed, J. B. Lippincott, Philadelphia, 1117-1138, 1994
 
2) Symonds JD, et al.:Incidence and phenotypes of childhood-onset genetic epilepsies:a prospective population-based national cohort. Brain 142:2303-2318, 2019
PubMed
3) Pressler RM, et al.:The ILAE classification of seizures and the epilepsies:Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia 62:615-628, 2021
PubMed
4) 石崎裕美子, 他:Midazolamにより誘発された新生児発作様異常運動. 脳と発達43:291-294, 2011
 
5) Lanska MJ, et al.:A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology 45:724-732, 1995
PubMed
6) 渡辺一功:新生児脳波入門. 新興医学出版社, 2002
 
7) 日本てんかん学会(編):症候性新生児発作. てんかん専門医ガイドブック. 第2版, 診断と治療社, 246-247, 2020
 
8) Abend NS, et al.:Neonatal seizures. In:Volpe JJ, et al.(eds), Volpe's Neurology of the Newborn. 6th ed, Elsevier, Amsterdam, 275-321, 2017
 
9) Shellhaas RA, et al.:Early-life epilepsy after acute symptomatic neonatal seizures:A prospective multicenter study. Epilepsia 62:1871-1882, 2021
PubMed
10) Cornet MC, et al.:Neonatal presentation of genetic epilepsies:Early differentiation from acute provoked seizures. Epilepsia 62:1907-1920, 2021
PubMed
11) Pisano T, et al.:Early and effective treatment of KCNQ2 encephalopathy. Epilepsia 56:685-691, 2015
PubMed
12) Wolff M, et al.:Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond. Epilepsia 60(Suppl. 3):S59-S67, 2019
 
13) Ohtsuka Y, et al.:Long-term follow-up of an individual with vitamin B6-dependent seizures. Dev Med Child Neurol 41:203-206, 1999
PubMed
14) Coughlin CR 2nd, et al.:Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis 44:178-192, 2021
 
15) Mills PB, et al.:Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy(ALDH7A1 deficiency). Brain 133:2148-2159, 2010
PubMed
16) Mikati MA, et al:Pyridoxine-dependent epilepsy:EEG investigations and long-term follow up. Electroencephalogr Clin Neurophysiol 78:215-221, 1991
PubMed
17) Nabbout R, et al:Pyridoxine dependent epilepsy:a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed 81:F125-F129, 1999
PubMed
18) Naasan G, et al.:Electroencephalographic changes in pyridoxine-dependant epilepsy:new observations. Epileptic Disord 11:293-300, 2009
PubMed
19) Schmitt B, et al.:Seizures and paroxysmal events:symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol 52:e133-e142, 2010
 
20) Bok LA, et al.:The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy. Epilepsia 51:2406-2411, 2010
PubMed
21) van Karnebeek CDM, et al.:Pyridoxine-Dependent Epilepsy:An Expanding Clinical Spectrum. Pediatr Neurol 59:6-12, 2016
PubMed
22) Ronen GM, et al.:Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 43:1355-1360, 1993
PubMed
23) Vigevano F, et al.:Benign neonatal and infantile seizures and epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 79-90, 2019
 
24) Grinton BE, et al.:Familial neonatal seizures in 36 families:Clinical and genetic features correlate with outcome. Epilepsia 56:1071-1080, 2015
PubMed
25) Zara F, et al.:Genetic testing in benign familial epilepsies of the first year of life:clinical and diagnostic significance. Epilepsia 54:425-436, 2013
PubMed
26) Hirsch E, et al.:Electroclinical signs of benign neonatal familial convulsions. Ann Neurol 34:835-841, 1993
PubMed
27) Plouin P:Benign idiopathic neonatal convulsions(familial and non-familial). In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed, John Libbey, London, 3-11, 1992
 
28) Dehan M, et al.:Fifth day fits. Arch Dis Child 57:400-401, 1982
PubMed
P.105 掲載の参考文献
1) 大田原俊輔, 他:特異な年齢依存性てんかん性脳症the early-infantile epileptic encephalopathy with suppression-burstに関する研究. 脳と発達8:270-280, 1976
 
2) 大田原俊輔:年齢依存性てんかん性脳症に関する研究. 脳と発達9:2-21, 1977
 
3) Ohtahara S, et al.:The early-infantile epileptic encephalopathy with suppression-burst:developmental aspects. Brain Dev 9:371-376, 1987
PubMed
4) Ohtahara S, et al.:Early-infantile epileptic encephalopathy with suppression-bursts. In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed, John Libbey, London, 25-34, 1992
 
5) Ohtsuka Y, et al.:Developmental aspects of epilepsy with special reference to age-dependent epileptic encephalopathy. Jpn J Psychiatry Neurol 40:307-313, 1986
PubMed
6) Ohtahara S, et al.:Epileptic encephalopathy in early infancy with suppression-burst. J Clin Neurophysiol 20:398-407, 2003
 
7) Aicardi J, et al.:Severe neonatal epilepsies with suppression-burst pattern. In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 4th ed, John Libbey Eurotext, Montrouge, 39-50, 2005
 
8) Kato M, et al.:A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern(Ohtahara syndrome). Am J Hum Genet 81:361-366, 2007
 
9) Saitsu H, et al.:De novo mutations in the gene encoding STXBP1(MUNC18-1)cause early infantile epileptic encephalopathy. Nat Genet 40:782-788, 2008
PubMed
10) Saitsu H, et al.:Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Ann Neurol 72:298-300, 2012
PubMed
11) Nakamura K, et al.:Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. Neurology 81:992-998, 2013
PubMed
12) 山下哲史, 他:Levetiracetam が著効したSTXBP1遺伝子変異による大田原症候群の1例. 脳と発達45:64-66, 2013
 
13) Kato M, et al.:Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia 54:1282-1287, 2013
PubMed
14) McTague A, et al.:The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol 15:304-316, 2016
PubMed
15) Perucca P, et al.:Identifying mutations in epilepsy genes:Impact on treatment selection. Epilepsy Res 152:18-30, 2019
PubMed
16) 大塚頌子, 他:Early-infantile epileptic encephalopathy with suppression-burst の経年的病像変容に関する検討. 臨床脳波27:86-96, 1985
 
17) Backx L, et al.:Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4. Eur J Hum Genet 17:378-382, 2009
PubMed
18) Kato M, et al.:PIGA mutations cause early-onset epileptic encephalopathies and distinctive features. Neurology 82:1587-1596, 2014
PubMed
19) Hansen J, et al.:De novo mutations in SIK1 cause a spectrum of developmental epilepsies. Am J Hum Genet 96:682-690, 2015
 
20) Cohen R, et al.:Two siblings with early infantile myoclonic encephalopathy due to mutation in the gene encoding mitochondrial glutamate/H+symporter SLC25A22. Eur J Paediatr Neurol 18:801-805, 2014
PubMed
21) Aicardi J:Early myoclonic encephalopathy(neonatal myoclonic encephalopathy). In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed, John Libbey, London, 13-23, 1992
 
22) Dalla Bernardina B, et al.:Early myoclonic epileptic encephalopathy(E. M. E. E.). Eur J Pediatr 140:248-252, 1983
 
23) 寺崎智行, 他:Glycine encephalopathy の長期追跡的検討. 脳と発達20:15-22, 1988
 
24) Rossi S, et al.:Early myoclonic encephalopathy and nonketotic hyperglycinemia. Pediatr Neurol 41:371-374, 2009
PubMed
25) 山磨康子, 他:サプレッションバーストを伴う早期乳児てんかん性脳症(大田原症候群)および早期ミオクロニー脳症. 小児内科27:1257-1264, 1995
 
26) Murakami N, et al.:Early infantile epileptic syndromes with suppression-bursts:early myoclonic encephalopathy vs. Ohtahara syndrome. Jpn J Psychiatry Neurol 47:197-200, 1993
PubMed
27) Akiyama T, et al.:Electroclinical characterization and classification of symptomatic epilepsies with very early onset by multiple correspondence analysis. Epilepsy Res 91:232-239, 2010
PubMed
28) 太田穂高, 他:Benign neonatal sleep myoclonus の1例. 脳と発達38:283-286, 2006
 
29) Daoust-Roy J, et al.:Benign neonatal sleep myoclonus. A differential diagnosis of neonatal seizures. Am J Dis Child 146:1236-1241, 1992
PubMed

第3章 乳児期の発作 ( 生後 3～12 か月 )

P.117 掲載の参考文献
1) Nishimoto H:Recent progress and future issues in the management of abusive head trauma. Neurol Med Chir 55:296-304, 2015
PubMed
2) Chemaly N, et al.:Early and long-term electroclinical features of patients with epilepsy and PCDH19 mutation. Epileptic Disord 20:457-467, 2018
PubMed
3) Kolc KL, et al.:A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy. Transl Psychiatry 10:127, 2020
PubMed
4) Fisher RS, et al.:ILAE official report:a practical clinical definition of epilepsy. Epilepsia 55:475-482, 2014
PubMed
5) Watanabe K, et al.:Benign partial epilepsy with secondarily generalized seizures in infancy. Epilepsia 34:635-638, 1993
PubMed
6) Coppola G, et al.:Migrating partial seizures in infancy:a malignant disorder with developmental arrest. Epilepsia 36:1017-1024, 1995
PubMed
7) Burgess R, et al.:The genetic landscape of epilepsy of infancy with migrating focal seizures. Ann Neurol 86:821-831, 2019
PubMed
8) Borlot F, et al.:KCNT1-related epilepsy:An international multicenter cohort of 27 pediatric cases. Epilepsia 61:679-692, 2020
PubMed
9) Barcia G, et al.:Epilepsy with migrating focal seizures:KCNT1 mutation hotspots and phenotype variability. Neurol Genet 5:e363, 2019
PubMed
10) Bahi-Buisson N, et al.:The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 49:1027-1037, 2008
PubMed
11) Klein KM, et al.:A distinctive seizure type in patients with CDKL5 mutations:Hypermotor-tonic-spasms sequence. Neurology 76:1436-1438, 2011
PubMed
12) Demarest ST, et al.:CDKL5 deficiency disorder:Relationship between genotype, epilepsy, cortical visual impairment, and development. Epilepsia 60:1733-1742, 2019
PubMed
13) Wolff M, et al.:Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond. Epilepsia 60(Suppl. 3):S59-S67, 2019
 
14) Dibbens LM, et al.:Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 45:546-551, 2013
PubMed
15) Leen WG, et al.:Glucose transporter-1 deficiency syndrome:the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655-670, 2010
PubMed
16) Klepper J, et al.:Glut1 Deficiency Syndrome(Glut1DS):State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open 5:354-365, 2020
 
17) Lombroso CT, et al.:Breathholding spells(cyanotic and pallid infantile syncope). Pediatrics 39:563-581, 1967
PubMed
18) Breningstall GN:Breath-holding spells. Pediatr Neurol 14:91-97, 1996
PubMed
19) Kanazawa O:Shuddering attacks-report of four children. Pediatr Neurol 23:421-424, 2000
PubMed
20) Harvey RJ, et al.:The genetics of hyperekplexia:more than startle! Trends Genet 24:439-447, 2008
PubMed
21) Ouvrier R, et al.:Paroxysmal tonic upgaze of childhood-a review. Brain Dev 27:185-188, 2005
PubMed
22) Akman CI, et al.:Diagnosing glucose transporter 1 deficiency at initial presentation facilitates early treatment. J Pediatr 171:220-226, 2016
PubMed
23) Drigo P, et al.:Benign paroxysmal torticollis of infancy. Brain Dev 22:169-172, 2000
PubMed
P.133 掲載の参考文献
1) Fusco L, et al.:Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia 34:671-678, 1993
PubMed
2) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
3) Lombroso CT:A prospective study of infantile spasms:clinical and therapeutic correlations. Epilepsia 24:135-158, 1983
PubMed
4) Ohtahara S, et al.:Prenatal etiologies of West syndrome. Epilepsia 34:716-722, 1993
PubMed
5) Ohtsuka Y, et al.:Aicardi syndrome:a longitudinal clinical and electroencephalographic study. Epilepsia 34:627-634, 1993
PubMed
6) Muir AM, et al.:Genetic heterogeneity in infantile spasms. Epilepsy Res 156:106181, 2019
PubMed
7) Pavone P, et al.:West syndrome:a comprehensive review. Neurol Sci 41:3547-3562, 2020
PubMed
8) Commission on Classification and Terminology of the International League Against Epilepsy:Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399, 1989
PubMed
9) Bisulli F, et al.:Ictal pattern of EEG and muscular activation in symptomatic infantile spasms:a videopolygraphic and computer analysis. Epilepsia 43:1559-1563, 2002
PubMed
10) Yamamoto N, et al.:Partial seizures evolving to infantile spasms. Epilepsia 29:34-40, 1988
PubMed
11) Ohtsuka Y, et al.:Partial seizures in West syndrome. Epilepsia 37:1060-1067, 1996
PubMed
12) Hrachovy RA, et al.:Hysarrhythmia:variations on the theme. Epilepsia 25:317-325, 1984
 
13) Hayashi Y, et al.:Predictive factors for relapse of epileptic spasms after adrenocorticotropic hormone therapy in West syndrome. Brain Dev 38:32-39, 2016
PubMed
14) 大塚頌子, 他:日本人の点頭てんかん患者に対するビガバトリン長期継続療法の安全性と有効性-多施設共同非盲検試験-. てんかん研究36:17-31, 2018
 
15) O'Callaghan FJK, et al.:Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms(ICISS):a randomised, multicentre, open-label trial. Lancet Neurol 16:33-42, 2017
PubMed
16) O'Callaghan FJK, et al.:Vigabatrin with hormonal treatment versus hormonal treatment alone(ICISS)for infantile spasms:18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health 2:715-725, 2018
PubMed
17) 今井由生, 他:West症候群に対するvitamin B6療法の再評価. 脳と発達41:457-461, 2009
 
18) Ohtsuka Y, et al.:Long-term follow-up of vitamin B6-responsive West syndrome. Pediatr Neurol 23:202-206, 2000
PubMed
19) Go CY, et al.:Evidence-based guideline update:medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 78:1974-1980, 2012
 
20) Gobbi G, et al.:Periodic spasms:an unclassified type of epileptic seizure in childhood. Dev Med Child Neurol 29:766-775, 1987
PubMed
21) Donat JF, et al.:Clinical imitators of infantile spasms. J Child Neurol 7:395-399, 1992
PubMed
22) Ricci S, et al.:Reflex myoclonic epilepsy in infancy:a new age-dependent idiopathic epileptic syndrome related to startle reaction. Epilepsia 36:342-348, 1995
PubMed
23) Guerrini R, et al.:Myoclonic epilepsies in infancy and early childhood. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Montrouge, 173-188, 2019
 
24) Mangano S, et al.:Benign myoclonic epilepsy in infancy:neuropsychological and behavioral outcome. Brain Dev 27:218-223, 2005
PubMed
25) Nellhaus G:Abnormal head movements of young children. Dev Med Child Neurol 25:384-389, 1983
PubMed
26) Antony JH, et al.:Spasmus nutans:a mistaken identity. Arch Neurol 37:373-375, 1980
PubMed
27) Mitchell R, et al.:Rhythmic habit patterns(stereotypies). Dev Med Child Neurol 19:545-550, 1977
 
28) Lombroso CT, et al.:Benign myoclonus of early infancy. Ann Neurol 1:138-143, 1977
PubMed
29) Dravet C, et al.:Benign myoclonus of early infancy or benign non-epileptic infantile spasms. Neuropediatrics 17:33-38, 1986
 
P.141 掲載の参考文献
1) Acharya JN, et al.:Seizure symptomatology in infants with localization-related epilepsy. Neurology 48:189-196, 1997
PubMed
2) Lortie A, et al.:Characteristics of epilepsy in focal cortical dysplasia in infancy. Epilepsy Res 51:133-145, 2002
PubMed
3) Watanabe K, et al.:Benign complex partial epilepsies in infancy. Pediatr Neurol 3:208-211, 1987
PubMed
4) Watanabe K, et al.:Benign partial epilepsy with secondarily generalized seizures in infancy. Epilepsia 34:635-638, 1993
PubMed
5) Vigevano F, et al.:Benign neonatal and infantile seizures and epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Moutrouge, 79-90, 2019
 
6) Okumura A, et al.:Long-term follow-up of patients with benign partial epilepsy in infancy. Epilepsia 47:181-185, 2006
PubMed
7) van Vliet R, et al.:PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions. Neurology 79:777-784, 2012
PubMed

第4章 幼児期前半の発作 ( 1～4 歳 )

P.156 掲載の参考文献
1) 日本小児神経学会(監), 熱性けいれん診療ガイドライン策定委員会(編):熱性けいれん診療ガイドライン2015. 診断と治療社, 2015
 
2) 大田原俊輔:熱性痙攣. 神経内科15:536-543, 1981
 
3) Nelson KB, et al.:Prognosis in children with febrile seizures. Pediatrics 61:720-727, 1978
PubMed
4) Gibbs FA, et al.:Atlas of Electroencephalography:Neurological and Psychiatric Disorders. vol. 3, Addison-Wesley, Reading, 1964
 
5) Alvarez N, et al.:Paroxysmal spike and wave activity in drowsiness in young children:its relationship to febrile convulsions. Electroencephalogr Clin Neurophysiol 56:406-413, 1983
PubMed
6) Scheffer IE, et al.:Generalized epilepsy with febrile seizure plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120:479-490, 1997
 
7) Berg AT, et al.:Complex febrile seizures. Epilepsia 37:126-133, 1996
PubMed
8) Falconer MA:Mesial temporal(Ammon's horn)sclerosis as a common cause of epilepsy. Etiology, treatment, and prevention. Lancet 2:767-770, 1974
PubMed
9) Akiyama M, et al.:A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 51:1043-1052, 2010
PubMed
10) Hattori J, et al.:A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 49:626-633, 2008
PubMed
11) Abe T, et al.:Infantile convulsions with mild gastroenteritis. Brain Dev 22:301-306, 2000
PubMed
12) Uemura N, et al.:Clinical features of benign convulsions with mild gastroenteritis. Brain Dev 24:745-749, 2002
PubMed
13) Maruyama K, et al.:Ictal EEG in patients with convulsions with mild gastroenteritis. Brain Dev 29:43-46, 2007
PubMed
14) 市山高志, 他:軽症胃腸炎関連けいれんに対する少量carbamazepine療法. 脳と発達37:493-497, 2005
 
15) Numoto S, et al.:A trial of lacosamide for benign convulsions with gastroenteritis. Brain Dev 42:551-554, 2020
PubMed
16) Giza CC:Traumatic brain injury in children. In:Swaiman KF, et al.(eds), Pediatric Neurology:Principles and Practice. vol.II, 4th ed, Mosby Elsevier, Philadelphia, 1401-1443, 2006
 
17) Beghi E:Overview of studies to prevent posttraumatic epilepsy. Epilepsia 44(Suppl. 10):21-26, 2003
 
18) Lewis RJ, et al.:Clinical predictors of post-traumatic seizures in children with head trauma. Ann Emerg Med 22:1114-1118, 1993
PubMed
19) Nishimoto H:Recent progress and future issues in the management of abusive head trauma. Neurol Med Chir 55:296-304, 2015
PubMed
20) Chang BS, et al.:Practice parameter:Antiepileptic drug prophylaxis in severe traumatic brain injury:Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 60:10-16, 2003
 
21) Agrawal A, et al.:Post-traumatic epilepsy:an overview. Clin Neurol Neurosurg 108:433-439, 2006
PubMed
22) Engel J Jr.:A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:report of the ILAE Task Force on Classification and Terminology. Epilepsia 42:796-803, 2001
PubMed
23) Ferrie C, et al.:Panayiotopoulos syndrome:a consensus view. Dev Med Child Neurol 48:236-240, 2006
PubMed
24) Covanis A, et al.:Panayiotopoulos syndrome and Gastaut type idiopathic childhood occipital epilepsy. In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 4th ed, John Libbey Eurotext, Montrouge, 227-253, 2005
 
25) Yoshinaga H, et al.:EEG dipole characteristics in Panayiotopoulos syndrome. Epilepsia 47:781-787, 2006
PubMed
26) Kikumoto K, et al.:EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome. Epileptic Disord 8:53-56, 2006
PubMed
27) Hirano Y, et al.:Neurobehavioral abnormalities may correlate with increased seizure burden in children with Panayiotopoulos syndrome. Pediatr Neurol 40:443-448, 2009
PubMed
28) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
29) Yamatogi Y, et al.:Multiple independent spike foci and epilepsy, with special reference to a new epileptic syndrome of "severe epilepsy with multiple independent spike foci". Epilepsy Res 70(Suppl. 1):S96-S104, 2006
 
P.171 掲載の参考文献
1) Gastaut H, et al.:Epileptic seizures:Clinical and Electrographic Features, Diagnosis and Treatment. Charles C Thomas Publisher, Springfield, 1972
 
2) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
3) Ohtahara S, et al.:Lennox-Gastaut syndrome:a new vista. Psychiatry Clin Neurosci 49:S179-S183, 1995
PubMed
4) Ikeno T, et al.:An analytic study of epileptic falls. Epilepsia 26:612-621, 1985
PubMed
5) Ohtsuka Y, et al.:Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome:a randomized double-blind placebo-controlled trial in Japan. Epilepsy Res 108:1627-1636, 2014
PubMed
6) 大田原俊輔, 他:Induced microseizures に関する臨床的脳波学的研究. てんかん研究1:51-60, 1983
 
7) 大塚頌子:抗てんかん薬による発作の増悪. Epilepsy 3:117-122, 2009
Medical*Online
8) 水川美智子:Severe epilepsy with multiple independent spike foci(SE-MISF)に関する臨床脳波学的研究. てんかん研究10:78-87, 1992
 
9) Yamatogi Y, et al.:Multiple independent spike foci and epilepsy, with special reference to a new epileptic syndrome of "severe epilepsy with multiple independent spike foci". Epilepsy Res 70(Suppl. 1):S96-S104, 2006
 
10) Gastaut H, et al.:Symptomatic partial epilepsies with secondary bilateral synchrony:differentiation from symptomatic generalized epilepsies of the Lennox-Gastaut type. In:Wieser HG, et al.(eds), Presurgical Evaluation of Epileptics. Springer Verlag, Berlin Heidelberg, 308-316, 1987
 
11) Dravet C, et al.:Severe myoclonic epilepsy in infancy:Dravet syndrome. In:Delgado-Escueta AV, et al.(eds), Myoclonic Epilepsies. Advances in Neurology, vol. 95, Lippincott Williams & Wilkins, Philadelphia, 71-102, 2005
 
12) Dravet C, et al.:Dravet syndrome(previously severe myoclonic epilepsy in infancy). In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Montrouge, 139-172, 2019
 
13) Claes L, et al.:De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68:1327-1332, 2001
PubMed
14) Hattori J, et al.:A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 49:626-633, 2008
PubMed
15) Ohmori I, et al.:Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy. Epilepsia 47:1636-1642, 2006
PubMed
16) Ohtsuka Y et al.:Paroxysmal movement disorders in severe myoclonic epilepsy in infancy. Brain Dev 25:401-405, 2003
PubMed
17) 荻野竜也:Severe myoclonic epilepsy in infancyに関する臨床的脳波学的研究. てんかん研究4:114-126, 1986
 
18) 眞庭聡:Severe myoclonic epilepsy in infancyに関する縦断的研究. てんかん研究11:226-235, 1993
 
19) Yamada M, et al.:Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome:interim report of a post-marketing surveillance study in Japan. Epilepsy Res 170:106535, 2021.
PubMed
20) Akiyama M, et al.:A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 51:1043-1052, 2010
PubMed
21) Kaminska A, et al.:Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 36:15-29, 1999
PubMed
22) 大塚頌子(監), 小林勝弘:小児脳波-判読のためのアプローチ. 診断と治療社, 192-194, 2008
 
23) 大塚頌子(監), 小林勝弘:小児脳波-判読のためのアプローチ. 診断と治療社, 165-166, 2008
 
24) Guerrini R, et al.:Myoclonic epilepsies in infancy and early childhood. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Montrouge, 173-188, 2019
 
25) Ebach K, et al.:SCN1A mutation analysis in myoclonic astatic epilepsy and severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics 36:210-213, 2005
PubMed
P.175 掲載の参考文献
1) Fogarasi A, et al.:Predictive clinical factors for the differential diagnosis of childhood extratemporal seizures. Epilepsia 46:1280-1285, 2005
PubMed
2) Zhou L, et al.:Hyperekplexia:a treatable neurogenetic disease. Brain Dev 24:669-674, 2002
PubMed
3) Harvey RJ, et al.:The genetics of hyperekplexia:more than startle! Trends Genet 24:439-447, 2008
PubMed
4) Ikeno T, et al.:An analytic study of epileptic falls. Epilepsia 26:612-621, 1985
PubMed
P.182 掲載の参考文献
1) Rubboli G, et al.:Idiopathic generalized epilepsy(IGE)syndromes in development:IGE with absences of early childhood, IGE with phantom absences, and perioral myoclonia with absences. Epilepsia 50(Suppl. 5):24-28, 2009
 
2) Klepper J, et al.:Glut1 Deficiency Syndrome(Glut1DS):State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open 5:354-365, 2020
 
3) Suls A, et al.:Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 66:415-419, 2009
PubMed
4) Afawi Z, et al.:Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 51:2466-2469, 2010
PubMed
5) Koch H, et al.:The glucose transporter type 1(Glut1)syndromes. Epilepsy Behav 91:90-93, 2019
PubMed
6) Wang D, et al.:Glucose Transporter Type 1 Deficiency Syndrome. In:Adam MP, et al.(eds), GeneReviews(R)[Internet]. University of Washington, Seattle, 2002[updated 2018]
 
7) Fogarasi A, et al.:Age-dependent seizure semiology in temporal lobe epilepsy. Epilepsia 48:1697-1702, 2007
PubMed
8) Fogarasi A, et al.:A detailed analysis of frontal lobe seizure semiology in children younger than 7years. Epilepsia 42:80-85, 2001
 
9) Stores G:Aspects of parasomnias in childhood and adolescence. Arch Dis Child 94:63-69, 2009
PubMed
10) Anders TF, et al.:Pediatric sleep disorders:a review of the past 10years. J Am Acad Child Adolesc Psychiatry 36:9-20, 1997
PubMed
11) Daly LP, et al.:Presenting features of idiopathic ketotic hypoglycemia. J Emerg Med 25:39-43, 2003
PubMed

第5章 幼児期後半～学童期中期の発作 ( 5～9 歳 )

P.191 掲載の参考文献
1) Demirbilek V, et al.:Self-limited focal epilepsies in childhood. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 219-260, 2019
 
2) Commission on Classification and Terminology of the International League Against Epilepsy:Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399, 1989
PubMed
3) Lemke JR, et al.:Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 45:1067-1072, 2013
PubMed
4) Yoshinaga H, et al.:Dipole tracing in childhood epilepsy with special reference to rolandic epilepsy. Brain Topogr 4:193-199, 1992
PubMed
5) Lundberg S, et al.:Rolandic epilepsy:a challenge in terminology and classification. Eur J Paediatr Neurol 7:239-241, 2003
PubMed
P.197 掲載の参考文献
1) Jabbour JT, et al.:Epidemiology of subacute sclerosing panencephalitis(SSPE):A report of the SSPE registry. JAMA 220:959-962, 1972
PubMed
2) Jabbour JT, et al.:Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases. JAMA 207:2248-2254, 1969
PubMed
3) Jabbour JT, et al.:SSPE:clinical staging, course and frequency. Arch Neurol 32:493-494, 1975
 
4) 大塚頌子(監), 小林勝弘:小児脳波-判読のためのアプローチ. 診断と治療社, 2008
 
5) 三宅進, 他:亜急性硬化性全脳炎の臨床脳波学的検討. 脳と発達17:29-36, 1985
 
6) 友田明美, 他:亜急性硬化性全脳炎に対するribavirin併用療法に関する全国調査. 脳と発達35:321-326, 2003
 
P.202 掲載の参考文献
1) Egli M, et al.:The axial spasm-the predominant type of drop seizure in patients with secondary generalized epilepsy. Epilepsia 26:401-415, 1985
PubMed
2) Geier S, et al.:The seizures of frontal lobe epilepsy. A study of clinical manifestations. Neurology 27:951-958, 1977
PubMed
3) Pazzaglia P, et al.:Drop attacks:an ominous change in the evolution of partial epilepsy. Neurology 35:1725-1730, 1985
PubMed
4) Satow T, et al.:Partial epilepsy manifesting atonic seizure:report of two cases. Epilepsia 43:1425-1431, 2002
PubMed
5) Zhou L, et al.:Hyperekplexia:a treatable neurogenetic disease. Brain Dev 24:669-674, 2002
PubMed
6) Harvey RJ, et al.:The genetics of hyperekplexia:more than startle! Trends Genet 24:439-447, 2008
PubMed
7) 大塚頌子(監), 小林勝弘:小児脳波-判読のためのアプローチ. 診断と治療社, 84, 2008
 
P.214 掲載の参考文献
1) 河内明宏, 他:日本夜尿症学会-夜尿症治療のガイドライン. 夜尿症研究10:5-13, 2005
 
2) Wallace RH, et al.:Mutant GABA(A)receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28:49-52, 2001
PubMed
3) Mullen SA, et al.:Genetic generalized epilepsies. Epilepsia 59:1148-1153, 2018
PubMed
4) Medina MT, et al.:Absence epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6h ed, John Libbey Eurotext, Paris, 285-320, 2019
 
5) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
6) Kobayashi K, et al.:Epilepsy with electrical status epilepticus during slow sleep and secondary bilateral synchrony. Epilepsia 35:1097-1103, 1994
PubMed
7) Viravan S, et al.:Jeavons syndrome existing as occipital cortex initiating generalized epilepsy. Epilepsia 52:1273-1279, 2011
PubMed
8) 井上英雄, 他:夜泣き, ねぼけ. 小児科診療47:577-582, 1984
 
9) Kales JD, et al.:Night terrors. Clinical characteristics and personality patterns. Arch Gen Psychiatry 37:1413-1417, 1980
PubMed
10) Stores G:Aspects of parasomnias in childhood and adolescence. Arch Dis Child 94:63-69, 2009
PubMed
11) Anders TF, et al.:Pediatric sleep disorders:a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36:9-20, 1997
PubMed
12) Lombroso CT:Paroxysmal choreoathetosis:an epileptic or non-epileptic disorder? Ital J Neurol Sci 16:271-277, 1995
PubMed
13) Akiyama T, et al.:Kinesigenic attacks with ictal electroencephalographic abnormalities. Pediatr Neurol 31:357-359, 2004
PubMed
14) Szepetowski P, et al.:Familial infantile convulsions and paroxysmal choreoathetosis:a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 61:889-898, 1997
 
15) Ohmori I, et al.:The relationship between paroxysmal kinesigenic choreoathetosis and epilepsy. Neuropediatrics 33:15-20, 2002
PubMed
16) van Vliet R, et al.:PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions. Neurology 79:777-784, 2012
PubMed
17) Boel M, et al.:Paroxysmal kinesigenic choreoathetosis. Neuropediatrics 15:215-217, 1984
PubMed
18) 国際頭痛学会・頭痛分類委員会(原著), 日本頭痛学会・国際頭痛分類委員会(訳):国際頭痛分類. 第3版, 医学書院, 2018
 

第6章 学童期後期～思春期以降の発作 ( 10 歳以降 )

P.222 掲載の参考文献
1) Berg AT, et al.:Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51:676-685, 2010
PubMed
2) Gelisse P, et al.:Epilepsy with generalized tonic-clonic seizures alone. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 379-388, 2019
 
3) Chung SS, et al.:Ictal eye closure is a reliable indicator for psychogenic nonepileptic seizures. Neurology 66:1730-1731, 2006
PubMed
4) Gumnit RJ, et al.:Psychogenic seizures. Epilepsia 27(Suppl. 2):S124-S129, 1986
 
5) Shen W, et al.:Presenting the diagnosis of pseudoseizure. Neurology 40:756-759, 1990
PubMed
P.231 掲載の参考文献
1) Ohtsuka Y, et al.:Long-term prognosis of the Lennox-Gastaut syndrome. Jpn J Psychiatry Neurol 44:257-264, 1990
PubMed
2) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
3) Mullen SA, et al.:Genetic generalized epilepsies. Epilepsia 59:1148-1153, 2018
PubMed
4) Genton P, et al.:Juvenile myoclonic epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 329-356, 2019
 
5) 井上有史, 他:非言語性高次大脳機能によって誘発される反射てんかんについて. てんかん研究10:1-9, 1992
 
6) 井上拓志, 他:書字・計算などの神経心理学的課題により発作が誘発された反射てんかんの1例. 臨床脳波51:449-453, 2009
 
7) Michelucci R, et al.:Progressive myoclonus epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 571-610, 2019
 
8) Shahwan A, et al.:Progressive myoclonic epilepsies:a review of genetic and therapeutic aspects. Lancet Neurol 4:239-248, 2005
PubMed
9) Pennacchio LA, et al.:Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy(EPM1). Science 271:1731-1734, 1996
PubMed
10) Minassian BA, et al.:Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20:171-174, 1998
 
11) Chan EM, et al.:Genetic mapping of a new Lafora progressive myoclonus epilepsy locus(EPM2B)on 6p22. J Med Genet 40:671-675, 2003
PubMed
12) Pampiglione G, et al.:So-called neuronal ceroid lipofuscinosis. Neurophysiological studies in 60 children. J Neurol Neurosurg Psychiatry 40:323-330, 1977
 
13) Naito H, et al.:Familial myoclonus epilepsy and choreoathetosis:hereditary dentatorubral-pallidoluysian atrophy. Neurology 32:798-807, 1982
PubMed
14) Koide R, et al.:Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy(DRPLA). Nat Genet 6:9-13, 1994
PubMed
15) Nagafuchi S, et al.:Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 6:14-18, 1994
PubMed
16) 伊予田邦昭, 他:小児期発病の歯状核・赤核・淡蒼球・ルイ体萎縮症のてんかん-electrical statusを伴いミオクローヌスと脱力を主徴とする特異な病像を呈した症例-. てんかん研究15:122-128, 1997
 
17) Kobayashi K, et al.:Age-related electrical status epilepticus during sleep and epileptic negative myoclonus in DRPLA. Neurology 66:772-773, 2006
PubMed
18) 笠井清登, 他:歯状核赤核・淡蒼球ルイ体萎縮症(DRPLA)患者における体性感覚・聴覚脳幹誘発電位の所見-他の進行性ミオクローヌスてんかんとの比較. てんかん研究16:184-192, 1998
 
19) Fukuhara N, et al.:Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities):disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 47:117-133, 1980
 
P.236 掲載の参考文献
1) Nevsimalova S:Narcolepsy in childhood. Sleep Med Rev 13:169-180, 2009
PubMed
2) Harvey RJ, et al.:The genetics of hyperekplexia:more than startle! Trends Genet 24:439-447, 2008
PubMed
3) Landau WM, et al.:Clinical neuromythology XV. Feinting science:neurocardiogenic syncope and collateral vasovagal confusion. Neurology 46:609-618, 1996
PubMed
4) Moodley M:Syncope and postural orthostatic tachycardia syndrome. In:Swaiman KF, et al.(eds), Swaiman's Pediatric Neurology:Principles and Practice. 6th ed, Elsevier, 660-666, 2017
 
5) 循環器病の診断と治療に関するガイドライン(2011年度合同研究班):失神の診断・治療ガイドライン(2012年改訂版). [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2012_inoue_h.pdf]
 
6) Stewart JM:Orthostatic intolerance in pediatrics. J Pediatr 140:404-411, 2002
 
7) Tanaka H, et al.:Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Pediatr Int 51:169-179, 2009
PubMed
8) Gelisse P, et al.:Video-EEG in syncopal attack due to ocular compression in an adolescent mistreated for epilepsy. Epileptic Disord 9:174-178, 2007
 
9) Horrocks IA, et al.:Anoxic-epileptic seizures:observational study of epileptic seizures induced by syncopes. Arch Dis Child 90:1283-1287, 2005
PubMed
P.251 掲載の参考文献
1) Medina MT, et al.:Absence epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6h ed, John Libbey Eurotext, Paris, 285-320, 2019
 
2) Blumcke I, et al.:The clinicopathologic spectrum of focal cortical dysplasias:a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158-174, 2011
 
3) Falconer MA:Mesial temporal(Ammon's horn)sclerosis as a common cause of epilepsy. Etiology, treatment, and prevention. Lancet 2:767-770, 1974
PubMed
4) Foiadelli T, et al.:Subtraction Ictal SPECT coregistered to MRI (SISCOM)as a guide in localizing childhood epilepsy. Epilepsia Open 5:61-72, 2019
PubMed
5) Leutmezer F, et al.:Postictal nose wiping:a lateralizing sign in temporal lobe complex partial seizures. Neurology 51:1175-1177, 1998
PubMed
6) Michelucci R, et al.:Lateral temporal lobe epilepsies:clinical and genetic features. Epilepsia 50(Suppl. 5):52-54, 2009
 
7) Bisulli F, et al.:Idiopathic partial epilepsy with auditory features(IPEAF):a clinical and genetic study of 53 sporadic cases. Brain 127:1343-1352, 2004
PubMed
8) Dazzo E, et al.:Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet 96:992-1000, 2015
PubMed
9) Kellinghaus C, et al.:Frontal lobe epilepsy. Epileptic Disord 6:223-239, 2004
PubMed
10) Fisher RS, et al.:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522-530, 2017
PubMed
11) Provini F, et al.:Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain 122:1017-1031, 1999
PubMed
12) Ryvlin P, et al.:Nocturnal frontal lobe epilepsy. Epilepsia 47(Suppl. 2):83-86, 2006
 
13) Hayman M, et al.:Autosomal dominant nocturnal frontal lobe epilepsy:demonstration of focal frontal onset and intrafamilial variation. Neurology 49:969-975, 1997
PubMed
14) Combi R, et al.:Autosomal dominant nocturnal frontal lobe epilepsy. A critical overview. J Neurol 251:923-934, 2004
PubMed
15) Steinlein OK, et al.:A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11:201-203, 1995
PubMed
16) Becchetti A, et al.:The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy. Front Physiol 6:22, 2015
PubMed
17) Heron SE, et al.:Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 44:1188-1190, 2012
PubMed
18) Picard F, et al.:DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology 82:2101-2106, 2014
PubMed
19) Salanova V, et al.:Parietal lobe epilepsy. Clinical manifestations and outcome in 82 patients treated surgically between 1929 and 1988. Brain 118:607-627, 1995
PubMed
20) Kuzniecky R:Symptomatic occipital lobe epilepsy. Epilepsia 39(Suppl. 4):S24-S31, 1998
 
21) Dibbens LM, et al.:Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 45:546-551, 2013
PubMed
22) Baulac S, et al.:Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 77:675-683, 2015
PubMed
23) Peterson PC, et al.:Pediatric narcolepsy. Brain Dev 30:609-623, 2008
PubMed
24) Nevsimalova S:Narcolepsy in childhood. Sleep Med Rev 13:169-180, 2009
PubMed
25) Overeem S, et al.:Cataplexy:‘tonic immobility'rather than'REM-sleep atonia'? Sleep Med 3:471-477, 2002
 
26) Vanier MT:Niemann-Pick disease type C. Orphanet J Rare Dis 5:16, 2010
PubMed
27) Nishino S, et al.:Hypocretin(orexin)deficiency in human narcolepsy. Lancet 355:39-40, 2000
PubMed

第7章 特殊な発作およびてんかん

P.262 掲載の参考文献
1) Commission on Classification and Terminology of the International League Against Epilepsy:Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489-501, 1981
PubMed
2) Working Group on Status Epilepticus:Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 270:854-859, 1993
 
3) Shinnar S, et al.:In whom does status epilepticus occur:age-related differences in children. Epilepsia 38:907-914, 1997
PubMed
4) Trinka E, et al.:A definition and classification of status epilepticus-Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56:1515-1523, 2015
PubMed
5) Haut SR, et al.:Seizure clustering:risks and outcomes. Epilepsia 46:146-149, 2005
PubMed
6) Shorvon S:Status Epilepticus:Its Clinical Features and Treatment in Children and Adults. Cambridge University Press, Cambridge, 1994
 
7) Ohtahara S, et al.:Non-convulsive status epilepticus in childhood. Folia Psychiatr Neurol Jpn 33:345-351, 1979
PubMed
8) Hesdorffer DC, et al.:Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 50:735-741, 1998
PubMed
9) Nishiyama I, et al.:An epidemiological study of children with status epilepticus in Okayama, Japan. Epilepsia 48:1133-1137, 2007
PubMed
10) Chin RFM, et al.:Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood:prospective population-based study. Lancet 368:222-229, 2006
PubMed
11) Klopstock T, et al.:Age and cause of death in mitochondrial diseases. Neurology 53:855-857, 1999
PubMed
12) Battaglia A, et al.:Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome:experience with 87 patients. Dev Med Child Neurol 51:373-380, 2009
PubMed
13) Meldrum BS, et al.:Physiology of status epilepticus in primates. Arch Neurol 28:1-9, 1973
PubMed
14) Lothman E:The biochemical basis and pathophysiology of status epilepticus. Neurology 40(5 Suppl. 2):13-23, 1990
 
15) Brown JK, et al.:Status epilepticus. I:pathogenesis. Dev Med Child Neurol 33:3-17, 1991
PubMed
16) Di Bonaventura C, et al.:Diffusion-weighted magnetic resonance imaging in patients with partial status epilepticus. Epilepsia 50(Suppl.1):45-52, 2009
 
17) Oppenheim C, et al.:Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 69:248-250, 2000
PubMed
18) Aicardi J, et al.:Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia 11:187-197, 1970
PubMed
19) DeLorenzo RJ, et al.:Persistent nonconvulsive status epilepticus after the control of convulsive statue epilepticus. Epilepsia 39:833-840, 1998
 
20) Beniczky S, et al.:Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 54(Suppl. 6):28-29, 2013
 
21) Maganti R, et al.:Nonconvulsive status epilepticus. Epilepsy Behav 12:572-586, 2008
PubMed
22) Tay SKH, et al.:Nonconvulsive status epilepticus in children:clinical and EEG characteristics. Epilepsia 47:1504-1509, 2006
PubMed
23) Shorvon S, et al.:Status epilepticus in idiopathic generalized epilepsy. Epilepsia 46(Suppl. 9):73-79, 2005
 
24) Kikumoto K, et al.:Complex partial status epilepticus in children with epilepsy. Brain Dev 31:148-157, 2009
PubMed
25) Treiman DM, et al.:Complex partial status epilepticus. In:Delgado-Escueta AV, et al.(eds), Adv Neurol 34:Status Epilepticus:Mechanism of Brain Damage and Treatment, Raven Press, Philadelphia, 69-81, 1983
 
26) Dalla Bernardina B, et al.:Myoclonic epilepsy("myoclonic status")in non progressive encephalopathies. In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed, John Libbey, London, 89-96, 1992
 
27) Elia M:Myoclonic status in nonprogressive encephalopathies:an update. Epilepsia 50(Suppl. 5):41-44, 2009
 
28) Boyd SG, et al.:The EEG in early diagnosis of the Angelman(happy puppet)syndrome. Eur J Pediatr 147:508-513, 1988
PubMed
29) Ohtsuka Y, et al.:Relationship between severity of epilepsy and developmental outcome in Angelman syndrome. Brain Dev 27:95-100, 2005
PubMed
30) Inoue Y, et al.:Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 120:939-953, 1997
PubMed
31) Oguni H, et al.:The natural history of the syndrome of chronic encephalitis and epilepsy:a study of the MNI series of forty-eight cases. In:Andermann F, et al.(eds), Chronic Encephalitis and Epilepsy:Rasmussen's Syndrome. Butterworth-Heinemann, Boston, 7-35, 1991
 
32) Fusco L, et al.:Epilepsia partialis continua and neuronal migration anomalies. Brain Dev 14:323-328, 1992
PubMed
33) Bien CG, et al.:Epilepsia partialis continua:semiology and differential diagnoses. Epileptic Disord 10:3-7, 2008
PubMed
34) Riquet A, et al.:Epilepsia partialis continua and defects in the mitochondrial respiratory chain. Epilepsy Res 78:1-6, 2008
PubMed
35) 日本神経学会(監), 「てんかん診療ガイドライン」作成委員会(編):てんかん診療ガイドライン2018. 医学書院, 76-90, 2018
 
36) 日本小児神経学会(監), 小児けいれん重積治療ガイドライン策定ワーキンググループ(編):小児けいれん重積治療ガイドライン2017. 診断と治療社, 2017
 
37) Yasiry Z, et al.:The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus:a meta-analysis of published studies. Seizure 23:167-174, 2014
PubMed
38) Strzelczyk A, et al.:Lacosamide in status epileptics:Systematic review of current evidence. Epilepsia 58:933-950, 2017
PubMed
39) Claassen J, et al.:Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam:a systematic review. Epilepsia 43:146-153, 2002
 
P.265 掲載の参考文献
1) Elliott B, et al.:Delusions, illusions and hallucinations in epilepsy:1. Elementary phenomena. Epilepsy Res 85:162-171, 2009
PubMed
2) Demirbilek V, et al.:Self-limited focal epilepsies in childhood. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 219-260, 2019
 
3) Verrotti A, et al.:Clinical dissection of childhood occipital epilepsy of Gastaut and prognostic implication. Eur J Neurol 23:241-246, 2016
PubMed
4) Kaplan PW:Musicogenic epilepsy and epileptic music:a seizure's song. Epilepsy Behav 4:464-473, 2003
 
5) Wieser HG:Temporal lobe or psychomotor status epilepticus. A case report. Electroencephalogr Clin Neurophysiol 48:558-572, 1980
 
6) Sveinbjornsdottir S, et al.:Parietal and occipital lobe epilepsy:a review. Epilepsia 34:493-521, 1993
PubMed
7) Chen C, et al.:Olfactory auras in patients with temporal lobe epilepsy. Epilepsia 44:257-260, 2003
PubMed
8) Peltola ME, et al.:Anatomoelectroclinical features of SEEG-confirmed pure insular-onset epilepsy. Epilepsy Behav 105:106964, 2020
PubMed
9) 国際頭痛学会・頭痛分類委員会(原著), 日本頭痛学会・国際頭痛分類委員会(訳):国際頭痛分類. 第3版, 医学書院, 2018
 
10) 榎 日出夫:てんかんと頭痛. 日本小児科学会雑誌123:674-685, 2019
 
11) Akiyama M, et al.:Five pediatric cases of ictal fear with variable outcomes. Brain Dev 36:758-763, 2014
PubMed
12) Fogarasi A, et al.:Predictive clinical factors for the differential diagnosis of childhood extratemporal seizures. Epilepsia 46:1280-1285, 2005
PubMed
13) Dalla Bernardina B, et al.:Benign partial epilepsy with affective symptoms('benign psychomotor epilepsy'). In:Roger J, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed, John Libbey, London, 219-223, 1992
 
P.268 掲載の参考文献
1) Engel J Jr.:ILAE classification of epilepsy syndromes. Epilepsy Res 70(Suppl. 1):S5-S10, 2006
 
2) Ferlazzo E, et al.:Cortical triggers in generalized reflex seizures and epilepsies. Brain 128:700-710, 2005
PubMed
3) Waltz S, et al.:The different patterns of the photoparoxysmal response-a genetic study. Electroencephalogr Clin Neurophysiol 83:138-145, 1992
PubMed
4) Michelucci R, et al.:Progressive myoclonus epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 571-610, 2019
 
5) Guerrini R, et al.:Idiopathic photosensitive occipital lobe epilepsy. Epilepsia 36:883-891, 1995
PubMed
6) Funatsuka M, et al.:Study on photo-pattern sensitivity in patients with electronic screen game-induced seizures(ESGS):effects of spatial resolution, brightness, and pattern movement. Epilepsia 42:1185-1197, 2001
 
7) Tekin Guveli B, et al.:Eye closure sensitivity in juvenile myoclonic epilepsy and its effect on prognosis. Seizure 22:867-871, 2013
PubMed
8) Inoue Y, et al.:Complex reflex epilepsies. In:Bureau M, et al.(eds), Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed, John Libbey Eurotext, Paris, 521-536, 2019
 
9) 田中 司, 他:特定の言葉で誘発される反射てんかんの1 例. てんかん研究2:147-154, 1984
 
10) D'Souza WJ, et al.:Toothbrushing-induced epilepsy with structural lesions in the primary somatosensory area. Neurology 68:769-771, 2007
PubMed
11) Kanemoto K, et al.:Rub epilepsy:a somatosensory evoked reflex epilepsy induced by prolonged cutaneous stimulation. J Neurol Neurosurg Psychiatry 70:541-543, 2001
PubMed
12) Tibussek D, et al.:Proven startle-provoked epileptic seizures in childhood:semiologic and electrophysiologic variability. Epilepsia 47:1050-1058, 2006
PubMed
13) Yang Z, et al.:Clinical and electrophysiological characteristics of startle epilepsy in childhood. Clin Neurophysiol 121:658-664, 2010
PubMed
14) d'Orsi G, et al.:Startle epilepsy associated with infantile hemiplegia(SEIH):video-polygraphic features and long-term outcome. Neuropediatrics 40:97-100, 2009
PubMed
15) Oguni H, et al.:Startle epilepsy with infantile hemiplegia:report of two cases improved by surgery. Epilepsia 39:93-98, 1998
PubMed
16) Martinez-Manas R, et al.:Intractable reflex audiogenic epilepsy successfully treated by peri-insular hemispherotomy. Seizure 13:486-490, 2004
PubMed
17) 井上拓志, 他:食事によって誘発されるシリーズ形成性spasmsを認めた小児例. 臨床脳波50:246-250, 2008
 
18) Loreto V, et al.:Eating epilepsy. Heterogeneity of ictal semiology:the role of video-EEG monitoring. Epileptic Disord 2:93-98, 2000
PubMed
19) Ritaccio AL, et al.:Cognition-induced epilepsy. Epilepsy Behav 3:496-501, 2002
PubMed
20) Ferlazzo E, et al.:Cortical triggers in generalized reflex seizures and epilepsies. Brain 128:700-710, 2005
PubMed
21) 井上拓志, 他:書字・計算などの神経心理学的課題により発作が誘発された反射てんかんの1例. 臨床脳波51:449-453, 2009
 
P.270 掲載の参考文献
1) Striano S, et al.:Gelastic epilepsy:symptomatic and cryptogenic cases. Epilepsia 40:294-302, 1999
PubMed
2) Berkovic SF, et al.:Hypothalamic hamartomas and ictal laughter:evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann Neurol 23:429-439, 1988
PubMed
3) Munari C, et al.:Role of the hypothalamic hamartoma in the genesis of gelastic fits(a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol 95:154-160, 1995
PubMed
4) Kuzniecky R, et al.:Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol 42:60-67, 1997
PubMed
5) Sonoda M, et al.:Predictors of cognitive function in patients with hypothalamic hamartoma following stereotactic radiofrequency thermocoagulation surgery. Epilepsia 58:1556-1565, 2017
PubMed
6) Lopez-Laso E, et al.:Giant hypothalamic hamartoma and dacrystic seizures. Epileptic Disord 9:90-93, 2007
PubMed
7) Dan B, et al.:Dacrystic seizures reconsidered. Neuropediatrics 29:326-327, 1998
PubMed
P.275 掲載の参考文献
1) 高橋幸利:Rasmussen 症候群. てんかん研究36:667-671, 2019
 
2) Fukuyama T, et al.:Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1)in the clinical course of Rasmussen syndrome. Epilepsy Res 113:34-43, 2015
 
3) 高橋幸利, 他:ラスムッセン脳炎の特徴と治療の実際. 新薬と臨牀66:684-689, 2017
 
4) Bien CG, et al.:Pathogenesis, diagnosis and treatment of Rasmussen encephalitis:a European consensus statement. Brain 128:454-471, 2005
PubMed
5) Takahashi Y, et al.:Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood. Brain Dev 35:778-785, 2013
PubMed
6) 神 一敬:自己免疫性てんかん. 日本臨牀76:1002-1007, 2018
 
7) 高橋幸利, 他:自己免疫性脳炎/脳症. 神経治療学33:19-26, 2016
 
8) Pruss H:Autoantibodies in neurological disease. Nat Rev Immunol 21:798-813, 2021
PubMed
9) Cellucci T, et al.:Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm 7:e663, 2020
 
10) Toledano M, et al.:Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology 82:1578-1586, 2014
PubMed
11) Baysal-Kirac L, et al.:Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings. J Neurol 263:455-466, 2016
PubMed
12) Dubey D, et al.:Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 74:397-402, 2017
PubMed
13) Dalmau J, et al.:Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25-36, 2007
PubMed
14) Irani SR, et al.:N-methyl-D-aspartate antibody encephalitis:temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655-1667, 2010
 
15) Peltola J, et al.:Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46-50, 2000
PubMed
16) Steriade C, et al.:Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy:Conceptual definitions. Epilepsia 61:1341-1351, 2020
PubMed
17) 坂本光弘, 他:自己免疫性てんかん. 医学のあゆみ270:555-561, 2019
 
18) Sakuma H:Acute encephalitis with refractory, repetitive partial seizures. Brain Dev 31:510-514, 2009
PubMed
19) van Baalen A, et al.:Febrile infection-related epilepsy syndrome(FIRES):a nonencephalitic encephalopathy in childhood. Epilepsia 51:1323-1328, 2010
PubMed
20) Wilder-Smith EPV, et al.:The NORSE(new-onset refractory status epilepticus)syndrome:defining a disease entity. Ann Acad Med Singap 34:417-420, 2005
PubMed
21) Gaspard N, et al.:New-onset refractory status epilepticus(NORSE)and febrile infection-related epilepsy syndrome(FIRES):State of the art and perspectives. Epilepsia 59:745-752, 2018
PubMed
22) Saito Y, et al.:Acute encephalitis with refractory, repetitive partial seizures:case reports of this unusual post-encephalitic epilepsy. Brain Dev 29:147-156, 2007
PubMed
23) Specchio N, et al.:New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Dev Med Child Neurol 62:897-905, 2020
PubMed
24) Nabbout R, et al.:Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children(FIRES). Epilepsia 51:2033-2037, 2010
PubMed
P.277 掲載の参考文献
1) Nashef L, et al.:Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 53:227-233, 2012
PubMed
2) Annegers JF:United States perspective on definitions and classifications. Epilepsia 38(Suppl. 11):S9-S12, 1997
 
3) Shorvon S, et al.:Sudden unexpected death in epilepsy. Lancet 378:2028-2038, 2011
PubMed
4) Sveinsson O, et al.:The incidence of SUDEP:A nationwide population-based cohort study. Neurology 89:170-177, 2017
PubMed
5) Harden C, et al.:Practice guideline summary:sudden unexpected death in epilepsy incidence rates and risk factors:Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 88:1674-1680, 2017
 
6) Lhatoo SD, et al.:An electroclinical case-control study of sudden unexpected death in epilepsy. Ann Neurol 68:787-796, 2010
PubMed
7) Ryvlin P, et al.:Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units(MORTEMUS):a retrospective study. Lancet Neurol 12:966-977, 2013
PubMed
8) Kuo J, et al.:Postictal immobility and generalized EEG suppression are associated with the severity of respiratory dysfunction. Epilepsia 57:412-417, 2016
PubMed
9) Allen, LA, et al.:Cerebellar, limbic, and midbrain volume alterations in sudden unexpected death in epilepsy. Epilepsia 60:718-729, 2019
PubMed
10) Coll M, et al.:Update on the genetic basis of sudden unexpected death in epilepsy. Int J Mol Sci 20:1979, 2019
PubMed
11) Tsang MHY, et al.:Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy. Epilepsia Open 4:63-72, 2018
PubMed
12) Moller RS, et al.:Mutations in KCNT1 cause a spectrum of focal epilepsies. Epilepsia 56:e114-e120, 2015
 
P.281 掲載の参考文献
1) Patry G, et al.:Subclinical"electrical status epilepticus"induced by sleep in children. A clinical and electroencephalographic study of six cases. Arch Neurol 24:242-252, 1971
PubMed
2) Commission on Classification and Terminology of the International League Against Epilepsy:Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399, 1989
PubMed
3) Tassinari CA, et al.:Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia. Clin Neurophysiol 111(Suppl. 2):S94-S102, 2000
 
4) Galanopoulou AS, et al.:The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 22:279-295, 2000
PubMed
5) 大塚頌子:ESES症候群とてんかん性陰性ミオクローヌスを伴う非けいれん性てんかん重積状態. 別冊日本臨牀 新領域別症候群シリーズNo.31 神経症候群(第2版)(VI)その他の神経疾患を含めて. 363-376, 2014
 
6) 大塚頌子, 他:小児期におけるnon-convulsive status epilepticus の特異型に関する研究. てんかん研究1:107-115, 1983
 
7) Guerrini R, et al.:Epileptic negative myoclonus. Neurology 43:1078-1083, 1993
PubMed
8) Scheltens-de Boer M:Guidelines for EEG in encephalopathy related to ESES/CSWS in children. Epilepsia 50(Suppl. 7):13-17, 2009
 
9) 西林尚祐:徐波睡眠期に持続性棘徐波を示すてんかんの縦断的研究. てんかん研究14:1-11, 1996
 
10) Aicardi J, et al.:Atypical benign partial epilepsy of childhood. Dev Med Child Neurol 24:281-292, 1982
PubMed
11) Guerrini R, et al.:Multilobar polymicrogyria, intractable drop attack seizures, and sleep-related electrical status epilepticus. Neurology 51:504-512, 1998
PubMed
12) Kobayashi K, et al.:Epilepsy with electrical status epilepticus during slow sleep and secondary bilateral synchrony. Epilepsia 35:1097-1103, 1994
PubMed
13) Lemke JR, et al.:Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 45:1067-1072, 2013
PubMed
14) Lesca G, et al.:GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 45:1061-1066, 2013
PubMed
15) Deonna T, et al.:The spectrum of acquired cognitive disturbances in children with partial epilepsy and continuous spike-waves during sleep. A 4-year follow-up case study with prolonged reversible learning arrest and dysfluency. Eur J Paediatr Neurol 1:19-29, 1997
 
16) Genton P:When antiepileptic drugs aggravate epilepsy. Brain Dev 22:75-80, 2000
PubMed
17) Inutsuka M, et al.:Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev 28:281-286, 2006
PubMed
18) Hirsch E, et al.:Landau-Kleffner syndrome:a clinical and EEG study of five cases. Epilepsia 31:756-767, 1990
PubMed
19) Tassinari CA, et al.:Encephalopathy with status epilepticus during slow sleep:"the Penelope syndrome". Epilepsia 50(Suppl. 7):4-8, 2009
 
20) Roulet E, et al.:Prolonged intermittent drooling and oromotor dyspraxia in benign childhood epilepsy with centrotemporal spikes. Epilepsia 30:564-568, 1989
PubMed
21) Deonna TW, et al.:Speech and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes(BPERS). Relationship to the acquired aphasia-epilepsy syndrome. Neuropediatrics 24:83-87, 1993
 

書評

最近チェックした商品履歴

Loading...